AAAAAA

   
Results: 1-22 |
Results: 22
DEFICIENCY OF THE ATM PROTEIN EXPRESSION DEFINES AN AGGRESSIVE SUBGROUP OF B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA
Authors: STAROSTIK P MANSHOURI T OBRIEN S FREIREICH E KANTARJIAN H HAIDAR M LERNER S KEATING M ALBITAR M
Citation: P. Starostik et al., DEFICIENCY OF THE ATM PROTEIN EXPRESSION DEFINES AN AGGRESSIVE SUBGROUP OF B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA, Cancer research, 58(20), 1998, pp. 4552-4557
EXPRESSION PROFILE OF MDM-2 PROTEINS IN CHRONIC LYMPHOCYTIC-LEUKEMIA AND THEIR CLINICAL RELEVANCE
Authors: HAIDAR MA ELHAJJ H BUESORAMOS CE MANSHOURI T GLASSMAN A KEATING MJ ALBITAR M
Citation: Ma. Haidar et al., EXPRESSION PROFILE OF MDM-2 PROTEINS IN CHRONIC LYMPHOCYTIC-LEUKEMIA AND THEIR CLINICAL RELEVANCE, American journal of hematology, 54(3), 1997, pp. 189-195
EXPRESSION OF BCL-2 AND FAS IN CHRONIC MYELOGENOUS LEUKEMIA (CML)
Authors: ALBITAR M KANTARIJAN H MANSHOURI T OBRIEN S ANDREEFF M KORNBLAU S BERAN M KEATING M TALPAZ M
Citation: M. Albitar et al., EXPRESSION OF BCL-2 AND FAS IN CHRONIC MYELOGENOUS LEUKEMIA (CML), Blood, 90(10), 1997, pp. 3983-3983
FAVORABLE CYTOGENETIC GROUPS IN ACUTE MYELOID-LEUKEMIA (AML) DO NOT OVEREXPRESS C-MPL PROTEIN
Authors: ALBITAR M MANSHOURI T KANTARJIAN H KEATING M ESTROV Z FABER J FREIREICH E PIERCE S ESTEY E
Citation: M. Albitar et al., FAVORABLE CYTOGENETIC GROUPS IN ACUTE MYELOID-LEUKEMIA (AML) DO NOT OVEREXPRESS C-MPL PROTEIN, Blood, 90(10), 1997, pp. 273-273
THE ATM GENE IS DELETED IN A SUBGROUP OF B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA
Authors: STAROSTIK P MANSHOURI T OBRIEN S FREIREICH E KANTARJIAN H LERNER S KEATING M ALBITAR M
Citation: P. Starostik et al., THE ATM GENE IS DELETED IN A SUBGROUP OF B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA, Blood, 90(10), 1997, pp. 396-396
ALLELOTYPING OF CHRONIC LYMPHOCYTIC-LEUKEMIA
Authors: STAROSTIK P OBRIEN S MANSHOURI T HAIDAR M KANTARJIAN H FREIREICH E KEATING M ALBITAR M
Citation: P. Starostik et al., ALLELOTYPING OF CHRONIC LYMPHOCYTIC-LEUKEMIA, Blood, 90(10), 1997, pp. 397-397
MULTIDRUG-RESISTANCE (MDR) EXPRESSION IN CHRONIC MYELOGENOUS LEUKEMIA(CML)
Authors: KANTARJIAN H MANSHOURI T TALPAZ M OBRIEN S KEATING M CORTES J PIERCE S ANDREEFF M KORNBLAU S ALBITAR M
Citation: H. Kantarjian et al., MULTIDRUG-RESISTANCE (MDR) EXPRESSION IN CHRONIC MYELOGENOUS LEUKEMIA(CML), Blood, 90(10), 1997, pp. 2236-2236
DOWN-REGULATION OF RAR-ALPHA IN MICE BY ANTISENSE TRANSGENE LEADS TO A COMPENSATORY INCREASE IN RAR-BETA AND RAR-GAMMA AND DEVELOPMENT OF LYMPHOMA
Authors: MANSHOURI T YANG Y LIN H STASS SA GLASSMAN AB KEATING MJ ALBITAR M
Citation: T. Manshouri et al., DOWN-REGULATION OF RAR-ALPHA IN MICE BY ANTISENSE TRANSGENE LEADS TO A COMPENSATORY INCREASE IN RAR-BETA AND RAR-GAMMA AND DEVELOPMENT OF LYMPHOMA, Blood, 89(7), 1997, pp. 2507-2515
INVOLVEMENT OF RETINOIC ACID RECEPTOR-ALPHA-MEDIATED SIGNALING PATHWAY IN INDUCTION OF CD38 CELL-SURFACE ANTIGEN
Authors: MEHTA K MCQUEEN T MANSHOURI T ANDREEFF M COLLINS S ALBITAR M
Citation: K. Mehta et al., INVOLVEMENT OF RETINOIC ACID RECEPTOR-ALPHA-MEDIATED SIGNALING PATHWAY IN INDUCTION OF CD38 CELL-SURFACE ANTIGEN, Blood, 89(10), 1997, pp. 3607-3614
ABNORMAL EXPRESSION OF MDM-2 IN BREAST CARCINOMAS
Authors: BUESORAMOS CE MANSHOURI T HAIDAR MA YANG Y MCCOWN P ORDONEZ N GLASSMAN A SNEIGE N ALBITAR M
Citation: Ce. Buesoramos et al., ABNORMAL EXPRESSION OF MDM-2 IN BREAST CARCINOMAS, Breast cancer research and treatment, 37(2), 1996, pp. 179-188
INCREASED BC12 TO BAX EXPRESSION RATIO IN VARIOUS TISSUES IN TRANSGENIC MICE WITH DEREGULATED LEVELS OF RETINOIC ACIDS RECEPTOR-ALPHA
Authors: HAIDAR MA MANSHOURI T MEHTA K ALBITAR M
Citation: Ma. Haidar et al., INCREASED BC12 TO BAX EXPRESSION RATIO IN VARIOUS TISSUES IN TRANSGENIC MICE WITH DEREGULATED LEVELS OF RETINOIC ACIDS RECEPTOR-ALPHA, Blood, 88(10), 1996, pp. 1528-1528
MULTIPLE PATTERNS OF MDM-2 DEREGULATION IN HUMAN LEUKEMIAS - IMPLICATIONS IN LEUKEMOGENESIS AND PROGNOSIS
Authors: BUESORAMOS CE MANSHOURI T HAIDAR MA HUH YO KEATING MJ ALBITAR M
Citation: Ce. Buesoramos et al., MULTIPLE PATTERNS OF MDM-2 DEREGULATION IN HUMAN LEUKEMIAS - IMPLICATIONS IN LEUKEMOGENESIS AND PROGNOSIS, Leukemia & lymphoma, 17(1-2), 1995, pp. 13-18
MOLECULAR ABNORMALITIES OF MDM-2 IN HUMAN SARCOMAS
Authors: BUESORAMOS CE YANG Y MANSHOURI T FELTZ L AYALA A GLASSMAN AB ALBITAR M
Citation: Ce. Buesoramos et al., MOLECULAR ABNORMALITIES OF MDM-2 IN HUMAN SARCOMAS, International journal of oncology, 7(5), 1995, pp. 1043-1048
ANTIBODY AND T-CELL RECOGNITION OF ALPHA-BUNGAROTOXIN AND ITS SYNTHETIC LOOP-PEPTIDES
Authors: ATASSI MZ DOLIMBEK BZ MANSHOURI T
Citation: Mz. Atassi et al., ANTIBODY AND T-CELL RECOGNITION OF ALPHA-BUNGAROTOXIN AND ITS SYNTHETIC LOOP-PEPTIDES, Molecular immunology, 32(12), 1995, pp. 919-929
HETEROGENEITY IN THE MOLECULAR ABNORMALITIES OF MDM-2 IN HUMAN SARCOMAS
Authors: BUESORAMOS CE YANG Y MANSHOURI T FELTZ L AYALA A ALBITAR M
Citation: Ce. Buesoramos et al., HETEROGENEITY IN THE MOLECULAR ABNORMALITIES OF MDM-2 IN HUMAN SARCOMAS, Laboratory investigation, 72(1), 1995, pp. 4-4
ABNORMAL MDM-2 PROTEIN EXPRESSION IN HUMAN LEUKEMIAS AND LYMPHOMAS
Authors: BUESORAMOS CE MANSHOURI T HAIDAR MA ELHAJ H HUH YO KEATING MJ PUGH W ALBITAR M
Citation: Ce. Buesoramos et al., ABNORMAL MDM-2 PROTEIN EXPRESSION IN HUMAN LEUKEMIAS AND LYMPHOMAS, Laboratory investigation, 72(1), 1995, pp. 107-107
MTS1 GENE DELETION IN PRIMARY LEUKEMIAS
Authors: HAIDER M MANSHOURI T FELTZ L KANTARJIAN H KEATING M BERAN M ALBITAR M
Citation: M. Haider et al., MTS1 GENE DELETION IN PRIMARY LEUKEMIAS, Laboratory investigation, 72(1), 1995, pp. 111-111
P16(INK4A) AND P15(INK4B) GENE DELETIONS IN PRIMARY LEUKEMIAS
Authors: HAIDAR MA CAO XB MANSHOURI T CHAN LL GLASSMAN A KANTARJIAN HM KEATING MJ BERAN MS ALBITAR M
Citation: Ma. Haidar et al., P16(INK4A) AND P15(INK4B) GENE DELETIONS IN PRIMARY LEUKEMIAS, Blood, 86(1), 1995, pp. 311-315
MDM-2 DEREGULATION IN BREAST CARCINOMAS AND SARCOMAS
Authors: BUESORAMOS C MANSHOURI T YANG Y SNEIGE N ALBITAR M
Citation: C. Buesoramos et al., MDM-2 DEREGULATION IN BREAST CARCINOMAS AND SARCOMAS, Laboratory investigation, 70(1), 1994, pp. 10000013-10000013
BIOLOGICAL-ACTIVITIES OF RAT ANTISERA RAISED AGAINST SYNTHETIC PEPTIDES OF HUMAN THYROTROPIN RECEPTOR
Authors: MATSUI I SAKATA S OGAWA T TAKUNO H SARUI H KOMAKI T MANSHOURI T ATASSI MZ
Citation: I. Matsui et al., BIOLOGICAL-ACTIVITIES OF RAT ANTISERA RAISED AGAINST SYNTHETIC PEPTIDES OF HUMAN THYROTROPIN RECEPTOR, Endocrine journal, 40(5), 1993, pp. 607-612
DESIGN OF PEPTIDE ENZYMES (PEPZYMES) - SURFACE-SIMULATION SYNTHETIC PEPTIDES THAT MIMIC THE CHYMOTRYPSIN AND TRYPSIN ACTIVE-SITES EXHIBIT THE ACTIVITY AND SPECIFICITY OF THE RESPECTIVE ENZYME
Authors: ATASSI MZ MANSHOURI T
Citation: Mz. Atassi et T. Manshouri, DESIGN OF PEPTIDE ENZYMES (PEPZYMES) - SURFACE-SIMULATION SYNTHETIC PEPTIDES THAT MIMIC THE CHYMOTRYPSIN AND TRYPSIN ACTIVE-SITES EXHIBIT THE ACTIVITY AND SPECIFICITY OF THE RESPECTIVE ENZYME, Proceedings of the National Academy of Sciences of the United Statesof America, 90(17), 1993, pp. 8282-8286
REDUCTION OF RAR-ALPHA PROTEIN EXPRESSION IN TRANSGENIC MICE EXPRESSING RAR-ALPHA ANTISENSE
Authors: MANSHOURI T YANG Y LIN H STASS SA ALBITAR M
Citation: T. Manshouri et al., REDUCTION OF RAR-ALPHA PROTEIN EXPRESSION IN TRANSGENIC MICE EXPRESSING RAR-ALPHA ANTISENSE, Blood, 82(10), 1993, pp. 10000111-10000111
Risultati: 1-22 |